Last week the Association of the British Pharmaceutical Industry (ABPI) held its Annual Conference:
The Pharmaceutical Industry are concerned about an “affordability conundrum”:
This BBC Report from November 2014: “Pharmaceutical Industry gets high on fat profits” documented that:
There will be many companies around the world who would like to be dealing with this kind of “affordability conundrum”.
Another area of concern to the industry was discussed at the 2015 ABPI Conference:
The closing session of the 2015 ABPI Conference was focused on the reputation of the pharmaceutical industry:
A panel discussion was part of this:
Andrew McConaghie of PharmaPhorum recorded this passage:
My view is that if the Pharmaceutical industry are concerned about their reputation then they should avoid such obvious scapegoating. Dr Goldacre has been and continues to be a world pioneer for scientific objectivity and it does the “reputation” of the British Pharmaceutical industry no credit to distort his work in this way.
Here is the view of the World Health Organisation: